Official 2024 U.S. DOL Form 5500 summary for Syndax Pharmaceuticals, INC. (Syndax Pharmaceuticals, INC. 401(k) Plan · EIN 32-0162505 · PN 001): $21.79M net assets, 268 active participants, and $15.99 per $10,000 (15.99 bps).
| Plan Sponsor | Syndax Pharmaceuticals, INC. |
|---|---|
| Filing Identifier | Syndax Pharmaceuticals, INC. 401(k) Plan · EIN 32-0162505 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (NY) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2024) | $21.79M |
| Active Participants | 268 |
| Direct Admin Fee Rate | $15.99 per $10,000 (15.99 bps) |
| Cohort Peer Median | $37.06 per $10,000 (37.06 bps) |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI